San Antonio, TX, United States of America

Jennifer Carew

This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Spectrum Pharmaceuticals, Inc., The University of Arizona. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Carew. Retrieved from https://idiyas.com/inventor/jennifer-carew

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 3 (Patent Applications = 1)

% Patents Active = 33.3

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)

Company Filing History:

2 out of 38

Spectrum Pharmaceuticals, Inc.

patents

1 out of 1,069

The University of Arizona

patents

Years Active: 2013-2026

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12629362 - Small molecule inhibitors of autophagy and histone deactylases and uses thereof (2026-05-19),

2. 9000031 - Thioxanthone-based autophagy inhibitor therapies to treat cancer (2015-04-07),

3. 8524762 - Thioxanthone-based autophagy inhibitor therapies to treat cancer (2013-09-03),

Title: Innovations in Cancer Treatment by Inventor Jennifer Carew

Introduction

Jennifer Carew is a prominent inventor based in San Antonio, TX (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapies. With a total of 3 patents, her work focuses on utilizing thioxanthone-based compounds to enhance cancer treatment methodologies.

Latest Patents

Jennifer Carew's latest patents include groundbreaking therapies that utilize thioxanthone-based autophagy inhibitors. These compositions are designed to treat cancer by providing pharmaceutical kits that comprise these innovative compounds. The patents detail methods of treating cancer using these inhibitors in conjunction with radiotherapy, showcasing her commitment to advancing cancer treatment options.

Career Highlights

Throughout her career, Jennifer has been associated with Spectrum Pharmaceuticals, Inc., where she has played a vital role in developing new cancer therapies. Her dedication to research and innovation has positioned her as a key figure in the pharmaceutical industry, particularly in the realm of oncology.

Collaborations

Jennifer has collaborated with notable colleagues, including Steffan Nawrocki and Guru Reddy. These partnerships have further enhanced her research efforts and contributed to the development of effective cancer treatment solutions.

Conclusion

Jennifer Carew's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the medical field. Her contributions through patents and collaborations continue to pave the way for advancements in cancer therapies.

Profile summary based on public USPTO records.